Development of a computed tomography-based radiomics nomogram for prediction of transarterial chemoembolization refractoriness in hepatocellular carcinoma

Figure 6 Kaplan-Meier curves of survival outcomes in different patient groups. A: Kaplan-Meier analysis of overall survival of high-risk (> 3.5) and low-risk (≤ 3.5) patients according to computed tomography (CT)-based radiomics nomogram in the training cohort; B: Kaplan-Meier analysis of overall survival of high-risk (> 3.5) and low-risk (≤ 3.5) patients according to CT-based radiomics nomogram in the validation cohort; C: Kaplan-Meier analysis of overall survival of high-risk (≥ 4) and low-risk (< 4) patients according to α-fetoprotein, Barcelona Clinic Liver Cancer, Child-Pugh, and Response (ABCR) score in the training cohort; D: Kaplan-Meier analysis of overall survival of high-risk (≥ 4) and low-risk (< 4) patients according to ABCR score in the validation cohort; E: Kaplan-Meier analysis of overall survival of high-risk (≥ 2.5) and low-risk (0-1.5) patients according to Assessment for Retreatment with Transarterial Chemoembolization (ART) score in the training cohort; F: Kaplan-Meier analysis of overall survival of high-risk (≥ 2.5) and low-risk (0-1.5) patients according to ART score in the validation cohort.